Home LiteratureArticle Details
PMID: 7910420 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole.

Toxicology and applied pharmacology ·Vol. 126 ·No. 1 ·1994-05-00 ·Pages 150-5

Borroz KI, Buetler TM, Eaton DL

Abstract

Dietary 2(3)-tert-butyl-4-hydroxyanisole (BHA) treatment has been shown to increase hepatic glutathione (GSH) content in rats and mice. Subsequent studies in our laboratory have demonstrated that hepatic gamma-glutamylcysteine synthetase (GCS) activity is increased in mice treated with dietary BHA. To test whether this increase in GCS activity follows an increase in hepatic messenger RNA for the large subunit of GCS (GCS-LS mRNA), a 390-base pair fragment corresponding to a region near the 5' end of the rat GCS-LS cDNA sequence was amplified using the PCR reaction and used to detect GCS-LS mRNA on Northern blots. Hepatic GSH, GCS activity, and GCS-LS mRNA levels were determined either in mice treated with BHA in the diet for 12 days or mice injected with diethyl maleate (DEM), phorone, and/or DL-buthionine-[S,R]-sulfoximine (BSO) over a 24 hr period. BHA caused a 1.5-fold increase in GSH levels, a 1.7-fold increase in hepatic GCS activity by Day 12, and a rapid 5-fold increase in hepatic GCS mRNA levels reaching maximal levels after 2-3 days. Partial depletion of GSH with either phorone (70%) or DEM (50%) resulted in a 4- to 5-fold increase in hepatic GCS-LS mRNA levels by 9 hr and a 1.5- to 2-fold increase in hepatic GSH and GCS activity by 24 hr. Depletion of GSH with the GCS enzyme inhibitor BSO had no effect on GCS mRNA expression, even though GSH was depleted to 30%. When BSO was combined with the phorone treatment GSH levels were depleted to < 10%, but the large increase in GCS-LS mRNA seen with phorone alone was greatly attenuated. These data suggest that depletion of GSH per se, is not sufficient to induce elevation of GCS-LS mRNA levels, but that the formation of GSH conjugates may be required to trigger GCS-LS mRNA induction. The increase in GCS-LS mRNA levels may account for the increase in GCS activity and elevation of GSH observed following BHA treatment, as well as the "rebound" of GSH above control levels observed 18-24 hr following depletion of GSH by other chemicals. These results are consistent with the Michael acceptor, hypothesis by Talalay.

MeSH Terms
Animals Base Sequence Buthionine Sulfoximine Butylated Hydroxyanisole/pharmacology DNA, Complementary Diet Fasting/metabolism Gene Expression Regulation, Enzymologic/drug effects Glutamate-Cysteine Ligase/drug effects,genetics Glutathione/metabolism Ketones/pharmacology Liver/drug effects,enzymology Male Maleates/pharmacology Methionine Sulfoximine/analogs & derivatives,pharmacology Mice Mice, Inbred Strains Molecular Sequence Data RNA, Messenger/drug effects
Chemicals
DNA, Complementary Ketones Maleates RNA, Messenger Methionine Sulfoximine Butylated Hydroxyanisole Buthionine Sulfoximine phorone Glutamate-Cysteine Ligase diethyl maleate Glutathione
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Borroz K I
Department of Environmental Health, University of Washington, Seattle 98195.
Buetler T M
Eaton D L
Article Info
Journal
Toxicology and applied pharmacology
Abbr.
Toxicol Appl Pharmacol
ISSN
0041-008X
Published
1994-05-00
Pages
150-5
Language
English
Region
United States
NLM ID
0416575
Subset
IM
Grants
NIEHS NIH HHS · ES-03933 · United States
NIEHS NIH HHS · ES-04696 · United States
NIEHS NIH HHS · ES-05780 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com